The present invention provides the TWEAK receptor and methods for
identifying and using agonists and antagonists of the TWEAK receptor. In
particular, the invention provides methods of screening for agonists and
antagonists and for treating diseases or conditions mediated by
angiogenesis, such as solid tumors and vascular deficiencies of cardiac
or peripheral tissue.